Vivan Life Sciences Pvt. Limited

Country/Region: India     State/Province: New Delhi

Company Introduction
VIVAN Life Sciences Pvt. Limited welcomes you to have a walk through of our products and our premises where we offer Drug Intermediates. As successful Drug Intermediates Manufacturer and Exporter, we have been working enthusiastically in this industry since 2005. Over the years our clients have always shown that they are fully satisfied form our Drug Intermediates and our 15 Years of export history clear witnesses that. Our corporate venture is located in NEW DELHI, India and , started off as a Private Owner entity under Agency with initial business capital estimating around US$10 Million - US$50 Million. In terms of Drug Intermediates export, we boast US$1 Million - US$2.5 Million and Australia,Canada,Switzerland,Germany,United Kingdom marketshare.As leading Drug Intermediates Manufacturer, we make sure that products are manufactured with bottom-line costs and excellent quality, making us able to score annual revenue worth Approx 0.5 Billion US Dollar. In addition, our representatives which include engineers, labor, support staff as well as high management personals, are all determined to build long-term relations with future clients to make sure that no one ever has a complaint regarding any of our Drug Intermediates. For more details contact Satish.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2005, 2005

Legal Status: Agency

Ownership: Private Owner

Employees: Above 1000 People

Factory Size: 50, 000-100, 000 square meters

R&D Team Size: 5 - 10 People

Certifications: FSC

Contact Information

Contact Person: Satish

Designation: Businessman

Department: Purchasing

Telephone: 919102230000000

Business Information

Main Markets: United Kingdom (26%) Switzerland (26%) Australia (21%) Germany (17%) Canada (15%)

Export Focus: Australia, Canada, Switzerland, Germany, United Kingdom

Contract Services: Design Service Offered

Trade & Financial Information

Annual Revenue: Approx 0.5 Billion US Dollar

Registered Capital: US$10 Million - US$50 Million

Export Percentage: 81% - 90%

Payment Terms: Bank wire (T/T)

Product Showcase
Drug Intermediates
Drug Intermediates

CL-Link > Health & Medicines in India Health & Medicines in New Delhi Health Care Supplement in India Health Care Supplement in New Delhi Drug Intermediates in India Drug Intermediates in New Delhi